50 results
Keyword Abba Remove keyword
-
List item
National expert: Amedeo Manfrin, Ministry Of Health (updated)
- Declaration of interests - 39.65 KB | PDF
- Curriculum Vitae - 47.29 KB | PDF
-
List item
National expert: Luca Massacesi, Italian Medicines Agency (updated)
- Declaration of interests - 47.97 KB | PDF
- Curriculum Vitae - 84.84 KB | PDF
1635_1641. 3. Massacesi L., Abbamondi A.L., Sarlo F. and Amaducci … 57:166_169. 4. Massacesi L., Abbamondi A.L., Giorgi C., Sarlo F … 80:55_64. 5. Massacesi L., Abbamondi A.L., Raimondi L., Giorgi … -
List item
National expert: Celine Chu, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 27.75 KB | PDF
1_Chu C, Abbara C, Noël_Hudson MS, Thomas_Bourgneuf … Aug;27(4):434_42. 5_Chu C, Abbara C, Tandia M, Publications Page … -
List item
Human medicine European public assessment report (EPAR): Arixtra
fondaparinux sodium, Venous Thrombosis; Pulmonary Embolism; Myocardial Infarction; Angina, Unstable
Date of authorisation: 20/03/2002, Revision: 35, Authorised, Last updated: 14/07/2023 -
List item
Human medicine European public assessment report (EPAR): Litfulo (updated)
ritlecitinib tosilate, Alopecia Areata
Date of authorisation: 15/09/2023,
, Authorised, Last updated: 18/09/2023
-
List item
National expert: Jens-Uwe Bleich, Norwegian Medicines Agency (updated)
- Declaration of interests - 39.7 KB | PDF
- Curriculum Vitae - 25.79 KB | PDF
Charakterisierung biologisch abbaubarer Mikropartikel mit dem Aerosol … -
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,, Revision: 30, Authorised, Last updated: 21/09/2023
-
List item
Human medicine European public assessment report (EPAR): Tezspire (updated)
tezepelumab, Asthma
Date of authorisation: 19/09/2022,, Revision: 7, Authorised, Last updated: 22/09/2023
-
List item
Human medicine European public assessment report (EPAR): Omvoh
Mirikizumab, Colitis, Ulcerative
Date of authorisation: 26/05/2023,, Revision: 1, Authorised, Last updated: 31/07/2023
-
List item
Human medicine European public assessment report (EPAR): Rapiscan
regadenoson, Myocardial Perfusion Imaging
Date of authorisation: 06/09/2010, Revision: 15, Authorised, Last updated: 25/05/2023 -
List item
Veterinary medicine European public assessment report (EPAR): Rheumocam
meloxicam, Dogs; Horses; Cats; Cattle; Pigs
Date of authorisation: 10/01/2008,
, Revision: 17, Authorised, Last updated: 18/11/2021
-
List item
Human medicine European public assessment report (EPAR): Cervarix
human papillomavirus1 type 16 L1 protein, human papillomavirus type 18 L1 protein, Papillomavirus Infections; Uterine Cervical Dysplasia; Immunization
Date of authorisation: 20/09/2007, Revision: 39, Authorised, Last updated: 23/05/2023 -
List item
Human medicine European public assessment report (EPAR): Savene
dexrazoxane hydrochloride, Extravasation of Diagnostic and Therapeutic Materials
Date of authorisation: 27/07/2006, Revision: 14, Authorised, Last updated: 08/10/2019 -
List item
National expert: Nils Lilienthal, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 30.29 KB | PDF
Lilienthal N, Nicco C, Scherer C, Abbas M, Zada AA, Coriat R, Burkholz … -
List item
National expert: Concetta Quintarelli, Italian Medicines Agency (updated)
- Declaration of interests - 41.14 KB | PDF
- Curriculum Vitae - 39.24 KB | PDF
I, Orlando D, Guercio M, Abbaszadeh Z, Sinibaldi M, Di Cecca … -
List item
National expert: Anthony Serracino-Inglott, Medicines Authority (updated)
- Declaration of interests - 40.92 KB | PDF
- Curriculum Vitae - 120.38 KB | PDF
-
List item
National expert: Annemieke Aartsma-Rus, European Medicines Agency (updated)
- Declaration of interests - 46.12 KB | PDF
- Curriculum Vitae - 77.84 KB | PDF
10.1186/s12014-023-09412-1. Cameron D, Abbassi-Daloii T, Heezen LGM, van de Velde … -
List item
National expert: Jose Manuel Zubeldia, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 34.86 KB | PDF
trial. Hourihane JO, Beyer K, Abbas A, Fernández_Rivas M, Turner … -
List item
Withdrawn application: Tibsovo
ivosidenib, date of withdrawal: 13/10/2020, Initial authorisation, Last updated: 16/04/2021 -
List item
Withdrawn application: Blectifor
caffeine citrate, date of withdrawal: 09/03/2017, Initial authorisation, Last updated: 16/05/2017 -
List item
National expert: Nadine Petitpain, Ministry Of Health (updated)
- Declaration of interests - 41.08 KB | PDF
- Curriculum Vitae - 60.25 KB | PDF
-
List item
National expert: Jan Welink, Medicines Evaluation Board (updated)
- Declaration of interests - 39.51 KB | PDF
- Curriculum Vitae - 41.63 KB | PDF
-
List item
National expert: Franco Granella, Italian Medicines Agency (updated)
- Declaration of interests - 42.47 KB | PDF
- Curriculum Vitae - 61.2 KB | PDF
-
List item
National expert: Massimo Siciliano, Italian Medicines Agency (updated)
- Declaration of interests - 39.22 KB | PDF
- Curriculum Vitae - 49.5 KB | PDF
-
List item
Referral: Cephalosporins
ceftiofur, cefquinome, associated names: Cobactan, Cefenil, Ceftiocyl, Cevaxel, Eficur, Excenel, Readycef, Virbacef, Truleva, Ceftiomax, Ceftiosan, Actionis, Cemay, Article 35
Status: European Commission final decision, opinion/position date: 13/10/2011, EC decision date: 13/01/2012, Last updated: 01/02/2012